What is the MBRX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Moleculin Biotech, Inc. (MBRX) price will be around $2.65 in the next 2 weeks. This means it will increase by 3.5273437500000018 from the last closing price. This prediction may vary from other time period filters for MBRX stock.

What can be the highest Possible price of MBRX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, MBRX can achieve the highest price of $2.77 which is 8.040611390831911 higher than last closing price. This prediction may vary from other time period filters for MBRX stock.

What can be the lowest Possible price of MBRX stock in next 2 weeks?

As per the forecast and algorithmic analysis, MBRX stock price can be as low as $2.53 which is -1.0684614506508567 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for MBRX stock.

Will MBRX stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that MBRX stock will gain3.5273437500000018 in the next 2 weeks. This prediction may vary from other time period filters for MBRX stock.

What is MBRX stock last closing price?

Last closing price of MBRX stock was $2.56.

What is MBRX stock price prediction?

MBRX stock price prediction means predicting the future closing prices of MBRX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of MBRX stock in a certain time period.

How we predict MBRX stock future prices?

If you are searching for MBRX stock forecast, analysis or price prediction, then you might be wondering what Moleculin Biotech, Inc. (MBRX) will do in the future. Our MBRX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This MBRX price prediction will likely answer most of your questions.

How frequent we update MBRX stock predictions?

We are updating the forecasts for the MBRX stock on daily basis.

Is using ML forecasting for MBRX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for MBRX stock same for all the time periods?

No, the prediction for MBRX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Moleculin Biotech, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$2.565.79%Since 2 Weeks

Predicted Price$2.653.53%For 2 Weeks

Upper Predicted Price$2.778.04%For 2 Weeks

Lower Predicted Price$2.53-1.07%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of MBRX will rise by +3.53% over the next 2 Weeks and hit $2.65 by Thursday, May 14, 2026. In that time frame, MBRX's share price is expected to range between $2.53 and $2.77.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 14, 2026	2.53	2.65	2.77
May 13, 2026	2.55	2.66	2.78
May 12, 2026	2.53	2.64	2.75
May 11, 2026	2.50	2.62	2.74
May 8, 2026	2.53	2.64	2.76
May 7, 2026	2.48	2.59	2.69
May 6, 2026	2.49	2.60	2.72
May 5, 2026	2.46	2.58	2.69
May 4, 2026	2.45	2.56	2.68
May 1, 2026	2.46	2.58	2.69

MBRX shares fell -1.95% in Friday, May 1, 2026's trading session, dropping from a previous close of $2.56 to move at $2.51. The stock demonstrated notable intraday movement (see MBRX's key stats for a full breakdown), fluctuating between $2.49 and $2.58, a +3.61% trading range. While recent weeks have seen some volatility, MBRX has managed to secure a +4.58% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 69.86K shares changing hands, 5.1K fewer than the previous session. This amounted to $175.35K in total market activity.

Will MBRX Continue Its Upward Trend?

According to analyst ratings and projections for MBRX, Moleculin Biotech, Inc. shares are anticipated to increase by +9.25%, potentially reaching $2.77 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for MBRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the MBRX stock forecast, now is a good time to buy MBRX stock because its current trading price is -5.29% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MBRX covering social and institutional perspectives.

MBRX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into MBRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.98% to 51.11%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 41.01%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 42.55%, maintains a neutral outlook for the long term. Insights into MBRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Moleculin Biotech Short-Term Forecasts

MBRX Forecast For Next 5 Days

Our algorithm anticipates Moleculin Biotech (MBRX) stock could hit $1.77 by May 08, 2026. This represents a -29.56% rise from today's price, following a +5.19% change over the past five days.

MBRX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Moleculin Biotech, Inc. (MBRX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.14, which would mean a -14.74% decrease from the current price of $2.51. Projections for this period range from a high of $3.69 to a low of $0.84.

MBRX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Moleculin Biotech's price over the next three months point to a drop. MBRX stock is expected to peak at $7.38 on Jun 09, 2026 before potentially dipping to $0.00 on Jul 31, 2026. On average, MBRX is likely to trade around $2.25 in the coming 90 days.

Moleculin Biotech Stock Forecast 2025

Based on our predictive models, Moleculin Biotech (MBRX) is expected to trade between $0.00 and $7.38 throughout 2026. This would result in an average price of $1.70, potentially offering investors a -32.27% return from current levels.

Moleculin Biotech, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Moleculin Biotech, Inc. (MBRX) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.00 and $7.15, settling at an average of $2.38. This could translate to a -5.18% loss.

June 2026

Based on current market signals, Moleculin Biotech, Inc. is projected to trend june 2026. We forecast a trading range from $0.00 to $7.38, with a likely average price of $2.44. Investors could expect a potential return of -2.79%.

July 2026

Our predictive algorithms indicate Moleculin Biotech, Inc. stock may see a shift in July 2026. The expected range spans $0.00–$7.07, with an average target of $1.97. This represents a cautious outlook and a possible loss of -21.51%.

August 2026

Analyzing established trends, Moleculin Biotech, Inc. looks set to move in August 2026. Projections place the stock between $0.00 and $6.70, averaging around $1.93. This suggests a -23.11% loss from current levels.

September 2026

Market indicators suggest Moleculin Biotech, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $5.89, with a midpoint forecast of $1.13. The stock might deliver a -54.98% loss.

October 2026

Forecasting for October 2026, models estimate that Moleculin Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $6.07, averaging $1.37. This signals a cautious trajectory with potential returns around -45.42%.

November 2026

According to our latest forecast models, Moleculin Biotech, Inc. (MBRX) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $6.63, settling at an average of $1.36. This could translate to a -45.82% loss.

December 2026

Based on current market signals, Moleculin Biotech, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $5.89, with a likely average price of $1.08. Investors could expect a potential return of -56.97%.

January 2027

Our predictive algorithms indicate Moleculin Biotech, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$6.28, with an average target of $0.95. This represents a cautious outlook and a possible loss of -62.15%.

February 2027

Analyzing established trends, Moleculin Biotech, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $5.26, averaging around $0.53. This suggests a -78.88% loss from current levels.

March 2027

Market indicators suggest Moleculin Biotech, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $5.65, with a midpoint forecast of $0.54. The stock might deliver a -78.49% loss.

April 2027

Forecasting for April 2027, models estimate that Moleculin Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $5.02, averaging $0.38. This signals a cautious trajectory with potential returns around -84.86%.

MBRX's history of dividends and stock splits also plays a role in long-term investor confidence.